Cardinal Health, Inc. Form 8-K Summary
Business Context and Reporting Period
Cardinal Health, Inc. filed a Current Report on Form 8-K on August 13, 2025. The filing reports a significant capital market transaction involving the issuance of new debt securities.
Key Financial Metrics
The filing details a debt offering with the following terms:
- Total Proceeds: $1,000,000,000 aggregate principal amount.
- Tranche 1: $600,000,000 of 4.500% Notes due 2030.
- Tranche 2: $400,000,000 of 5.150% Notes due 2035.
- Underwriters: Goldman Sachs & Co. LLC, BofA Securities, Inc., and Wells Fargo Securities, LLC.
The filing text does not provide clear values for revenue, profit, cash flow, margins, or existing liquidity metrics, as this report focuses solely on the debt issuance event.
Material Changes
The primary material change is the increase in the Company's outstanding debt obligations by $1.0 billion. This transaction was executed pursuant to an effective registration statement on Form S-3ASR (No. 333-289513).
Outlook, Risks, and Management Commentary
Management commentary is limited to the execution of the underwriting agreement. The filing incorporates the full Underwriting Agreement by reference for complete terms. No specific guidance, risk factors, or contingencies regarding future operations are detailed in this specific 8-K text beyond the standard disclosure of the debt offering.
Investor Verification Checklist
- Verify the final net proceeds after deducting underwriting discounts and commissions.
- Review the full Underwriting Agreement (Exhibit 1.1) for covenants, redemption rights, and use of proceeds.
- Assess the impact of the new interest rates (4.500% and 5.150%) on the Company's future interest expense and debt service coverage ratios.
- Confirm the Company's updated total debt load and leverage ratios post-issuance.